Cannara Biotech8CB0 
$0.45-17.31%24h
-17.31%24h
Global rank25019
Market cap$40.33M
Change 7d-11.89%
YTD Performance-22.52%
SP500 benchmarkUnderperform
P/E5.65
P/S1.00
Revenue$40.22M
Earnings$4.88M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech 8CB0 Total Debt
8CB0 Total Debt in 2022: $27.92M
According to Cannara Biotech latest financial reports the total debt is $27.92M, an decrease of -13.99% to 2022. At the end of 2022 company had $32.46M total debt. This figure represents the debts and financial obligations that Cannara Biotech combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Cannara Biotech 8CB0 Total Debt History from 2023 to 2022
-
Value:-
8CB0 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $27.92M | -13.99% |
| 2022 | $32.46M | 126.85% |
| 2021 | $14.31M | 63.94% |
| 2020 | $8.73M | -5.05% |
| 2019 | $9.19M | - |
View the Top Total Debt Stocks 
